Skip to main content

Advertisement

Log in

BCR-ABL-positive acute myeloid leukemia: About one case treated with ponatinib

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

An Erratum to this article was published on 19 November 2016

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127(20):2391–2405. doi:10.1182/blood-2016-03-643544

    Article  PubMed  Google Scholar 

  2. Reboursiere E, Chantepie S, Gac AC, Reman O (2015) Rare but authentic Philadelphia-positive acute myeloblastic leukemia: two case reports and a literature review of characteristics, treatment and outcome. Hematol Oncol Stem Cell Ther 8(1):28–33

    Article  PubMed  Google Scholar 

  3. Neuendorff NR, Burmeister T, Dörken B, Westermann J (2016) BCR-ABL-positive acute myeloid leukemia: a new entity? Analysis of clinical and molecular features. Ann Hematol 95(8):1211–1221. doi:10.1007/s00277-016-2721-z

    Article  CAS  PubMed  Google Scholar 

  4. Nacheva EP, Grace CD, Brazma D, Gancheva K, Howard-Reeves J, Rai L, Gale RE, Linch DC, Hills RK, Russell N, Burnett AK, Kottaridis PD (2013) Does BCR/ABL1 positive acute myeloid leukaemia exist? Br J Haematol 161(4):541–550. doi:10.1111/bjh.12301

    Article  CAS  PubMed  Google Scholar 

  5. Grimwade D, Ivey A, Huntly BJ (2016) Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance. Blood 127(1):29–41. doi:10.1182/blood-2015-07-604496

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Schnittger S, Haferlach C, Nadarajah N, Meggendorfer M, Fasan A, Rose D, Alpermann T, Kern W, Haferlach T (2014) CML Patients with Resistance to Tyrosine Kinase Inhibitors and without BCR-ABL1 Resistance Mutation Frequently Carry Other Gene Mutations. Blood 124:4516

    Google Scholar 

  7. Paschka P, Schlenk RF, Gaidzik VI et al (2015) ASXL1 mutations in younger adult patients with acute myeloid leukemia: a study by the German-Austrian Acute Myeloid Leukemia Study Group. Haematologica 100(3):324–330. doi:10.3324/haematol.2014.114157

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Neuendorff NR, Schwarz M, Hemmati P, Türkmen S, Bommer C, Burmeister T, Dörken B, le Coutre P, Arnold R, Westermann J (2015) BCR-ABL1(+) acute myeloid leukemia: clonal selection of a BCR-ABL1(−) subclone as a cause of refractory disease with nilotinib treatment. Acta Haematol 133(2):237–241. doi:10.1159/000368176

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Heiblig Maël.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

An erratum to this article is available at http://dx.doi.org/10.1007/s00277-016-2879-4.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Maël, H., Audrey, B., Evelyne, CB. et al. BCR-ABL-positive acute myeloid leukemia: About one case treated with ponatinib. Ann Hematol 96, 335–336 (2017). https://doi.org/10.1007/s00277-016-2855-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-016-2855-z

Keywords

Navigation